Programme allowing the import and store of controversial drug for use against Covid brought to an end
By James Stent
Science | 30 May 2022
Survey of blood donors in March finds 98% of adults are either vaccinated, previously infected or both
By James Stent
Science | 27 May 2022
South Africa can afford a much bigger public employment programme, argues top economist
By James Stent
News | 25 May 2022
The disease has been rare in rich countries for 50 years, and one reason is decent housing
By James Stent
Science | 10 May 2022
Vaccines against TB are much slower to develop than Covid ones
By James Stent
Science | 9 May 2022
Judge rules that agency defamed Pearl Munthali
By James Stent
Law | 20 April 2022
Why did she suddenly change her mind about 3Sixty Life’s future?
By James Stent
Feature | 1 April 2022
The Devil’s Peak Vredehoek Outreach programme takes a new look at a chronic problem
By James Stent
News | 24 March 2022
3Sixty Life: a lesson in how not to run a company, part two
By James Stent
News | 14 March 2022
3Sixty Life: a lesson in how not to run a company, part one
By James Stent
News | 10 March 2022
3Sixty Life, currently under curatorship, made huge loans which haven’t been repaid
By James Stent
News | 4 March 2022
Report finds 3Sixty Life, now in curatorship, used as “treasurer” for NUMSA-owned companies
By James Stent
News | 1 March 2022
Western Cape Parliament told PRASA is stabilising
By James Stent
News | 24 February 2022
Siyangena has appealed against the court judgment setting aside its contracts
By James Stent
News | 9 February 2022
Many scanned documents are impossible to read
By James Stent
Feature | 28 January 2022
Deaths have been massively underestimated in Africa
By Alex Welte, Nathan Geffen and James Stent
Science | 19 January 2022